Center Ventures, based in Taipei, Taiwan, is a pharmaceutical and biotechnology incubator platform company originally founded in 1959 as a pharmaceutical company. Since its founding, the company has grown to work with companies in the biotechnology industry chain, including small molecule drug R&D, protein and antibody development, pharmaceutical CDMO, pharmaceutical manufacturing and sales, medical devices, nutritional health and agricultural biotechnology, emerging medicine (stem cell and immune cell therapy), and industry investment fund and venture capital. With more than seventy years of practical experience and business expertise in biotechnology, Center Ventures supports high potential companies to address unmet medical needs. The company has invested in more than twenty biotech companies, eight of which have been successfully listed on the stock market. In 2017, Center Ventures financially backed Acepodia to develop its proprietary antibody-conjugated cells to help eradicate cancer.
For more information please visit: https://www.centerventures.com.tw/en